These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2836759)

  • 41. The differential diagnosis of anxiety. Psychiatric and medical disorders.
    Cameron OG
    Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA; Tesar GE; Rosenbaum JF; Woods SW
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Change in Bmax and Kd for [3H]flunitrazepam observed in the course washing rat brain tissue with distilled water.
    Korneyev AYa ; Factor MI
    Mol Pharmacol; 1983 Mar; 23(2):310-4. PubMed ID: 6132331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice.
    Caldji C; Diorio J; Anisman H; Meaney MJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1344-52. PubMed ID: 15085086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J; Vallejo J
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors in the panic-agoraphobia transition.
    Katerndahl DA
    J Am Board Fam Pract; 1989; 2(1):10-6. PubMed ID: 2635873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet serotonin uptake in panic disorder patients: a replication study.
    Norman TR; Judd FK; Burrows GD; McIntyre IM
    Psychiatry Res; 1989 Oct; 30(1):63-8. PubMed ID: 2594872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Rethink the panic disorder].
    Amami O; Aloulou J; Siala M; Aribi L
    Encephale; 2010 Apr; 36(2):100-4. PubMed ID: 20434625
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The phenomenological study of 90 patients with panic disorder, Part II.
    Argyle N; Roth M
    Psychiatr Dev; 1989; 7(3):187-209. PubMed ID: 2639356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of ergot alkaloids on 3H-flunitrazepam binding to mouse brain GABAA receptors.
    Tvrdeić A; Pericić D
    Coll Antropol; 2003; 27 Suppl 1():175-82. PubMed ID: 12955907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
    Pollack MH; Tesar GE; Rosenbaum JF; Spier SA
    J Clin Psychopharmacol; 1986 Oct; 6(5):302-4. PubMed ID: 3771814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional modulation of cerebral gamma-aminobutyric acidA receptor/benzodiazepine receptor/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate.
    Taguchi J; Kuriyama K
    J Pharmacol Exp Ther; 1990 May; 253(2):558-66. PubMed ID: 2159999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo [3H]flunitrazepam binding: imaging of receptor regulation.
    Ciliax BJ; Penney JB; Young AB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):749-57. PubMed ID: 3016249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postnatal handling reduces novelty-induced fear and increases [3H]flunitrazepam binding in rat brain.
    Bodnoff SR; Suranyi-Cadotte B; Quirion R; Meaney MJ
    Eur J Pharmacol; 1987 Nov; 144(1):105-7. PubMed ID: 2830116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Panic induction via inhalation of 5.5% CO2 enriched air: a single subject analysis of psychological and physiological effects.
    Sanderson WC; Rapee RM; Barlow DH
    Behav Res Ther; 1988; 26(4):333-5. PubMed ID: 3145734
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma serotonin levels in agoraphobia.
    Evans L; Schneider P; Ross-Lee L; Wiltshire B; Eadie M; Kenardy J; Hoey H
    Am J Psychiatry; 1985 Feb; 142(2):267. PubMed ID: 3970254
    [No Abstract]   [Full Text] [Related]  

  • 57. Benzodiazepine binding inhibitory activity: new supportive findings on its presence in psychiatric patients and further biochemical analyses.
    Marazziti D; Giannaccini G; Martini C; Simoncini M; Dell'Osso L; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(1):9-13. PubMed ID: 8884752
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholinergic-monoamine systems, depression, and panic.
    Dilsaver SC
    Biol Psychiatry; 1986 May; 21(5-6):571-3. PubMed ID: 3697449
    [No Abstract]   [Full Text] [Related]  

  • 59. A 3H-flunitrazepam binding inhibitor is present in psychiatric patients' sera.
    Marazziti D; Pietrini P; Martini C; Giannaccini G; Perugi G; Placidi GF; Cassano GB; Lucacchini A
    Neuropsychobiology; 1987; 18(2):74-6. PubMed ID: 2836759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further investigation on benzodiazepine binding inhibitory activity in patients with major depression or panic disorder and in healthy volunteers.
    Marazziti D; Michelini S; Martini C; Giannaccini G; Lucacchini A; Cassano GB
    Neuropsychobiology; 1989; 21(1):14-6. PubMed ID: 2554193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.